109 related articles for article (PubMed ID: 17507861)
1. [SAMD9 mutation in normophosphatemic familial tumoral calcinosis].
Dereure O
Ann Dermatol Venereol; 2007 May; 134(5 Pt 1):505. PubMed ID: 17507861
[No Abstract] [Full Text] [Related]
2. A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis.
Topaz O; Indelman M; Chefetz I; Geiger D; Metzker A; Altschuler Y; Choder M; Bercovich D; Uitto J; Bergman R; Richard G; Sprecher E
Am J Hum Genet; 2006 Oct; 79(4):759-64. PubMed ID: 16960814
[TBL] [Abstract][Full Text] [Related]
3. Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein.
Chefetz I; Ben Amitai D; Browning S; Skorecki K; Adir N; Thomas MG; Kogleck L; Topaz O; Indelman M; Uitto J; Richard G; Bradman N; Sprecher E
J Invest Dermatol; 2008 Jun; 128(6):1423-9. PubMed ID: 18094730
[TBL] [Abstract][Full Text] [Related]
4. Mouse Samd9l is not a functional paralogue of the human SAMD9, the gene mutated in normophosphataemic familial tumoral calcinosis.
Li Q; Guo H; Matsui H; Honda H; Inaba T; Sundberg JP; Sprecher E; Uitto J
Exp Dermatol; 2012 Jul; 21(7):554-6. PubMed ID: 22716256
[TBL] [Abstract][Full Text] [Related]
5. Clinical and genetic analysis of idiopathic normophosphatemic tumoral calcinosis in 19 patients.
Zuo QY; Cao X; Liu BY; Yan D; Xin Z; Niu XH; Li C; Deng W; Dong ZY; Yang JK
J Endocrinol Invest; 2020 Feb; 43(2):173-183. PubMed ID: 31535357
[TBL] [Abstract][Full Text] [Related]
6. Functional characterization of SAMD9, a protein deficient in normophosphatemic familial tumoral calcinosis.
Hershkovitz D; Gross Y; Nahum S; Yehezkel S; Sarig O; Uitto J; Sprecher E
J Invest Dermatol; 2011 Mar; 131(3):662-9. PubMed ID: 21160498
[TBL] [Abstract][Full Text] [Related]
7. [Familial tumoral calcinosis with hyperphosphatemia is heterogeneous and associated with mutations in GALNT3 or FGF-23].
Dereure O
Ann Dermatol Venereol; 2006 Apr; 133(4):408. PubMed ID: 16733465
[No Abstract] [Full Text] [Related]
8. Reply to ultrastructural study of the clinically uninvolved skin in familial tumoral calcinosis caused by mutations in GALNT3.
Bergman R; Topaz O; Iancu TC; Sprecher E
Am J Dermatopathol; 2006 Aug; 28(4):372-3. PubMed ID: 16871046
[No Abstract] [Full Text] [Related]
9. A novel homozygous missense mutation in FGF23 causes Familial Tumoral Calcinosis associated with disseminated visceral calcification.
Chefetz I; Heller R; Galli-Tsinopoulou A; Richard G; Wollnik B; Indelman M; Koerber F; Topaz O; Bergman R; Sprecher E; Schoenau E
Hum Genet; 2005 Nov; 118(2):261-6. PubMed ID: 16151858
[TBL] [Abstract][Full Text] [Related]
10. Recent advances in tumoral calcinosis have been principally concerned with the discovery of genetic mutations responsible for this disorder.
Slavin RE
Am J Dermatopathol; 2006 Aug; 28(4):374-5. PubMed ID: 16871047
[No Abstract] [Full Text] [Related]
11. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.
Ichikawa S; Imel EA; Kreiter ML; Yu X; Mackenzie DS; Sorenson AH; Goetz R; Mohammadi M; White KE; Econs MJ
J Musculoskelet Neuronal Interact; 2007; 7(4):318-9. PubMed ID: 18094491
[No Abstract] [Full Text] [Related]
12. A homozygous frameshift variant expands the clinical spectrum of SAMD9 gene defects.
Mehawej C; Ibrahim M; Khalife L; Chouery E; El Hachem S; Sayad A; El Traboulsi A; Inati A; Megarbane A
Clin Genet; 2024 Feb; 105(2):202-208. PubMed ID: 37830462
[TBL] [Abstract][Full Text] [Related]
13. Tumoral calcinosis: a look into the metabolic mirror of phosphate homeostasis.
de Beur SM
J Clin Endocrinol Metab; 2005 Apr; 90(4):2469-71. PubMed ID: 15814777
[No Abstract] [Full Text] [Related]
14. A novel mutation in fibroblast growth factor 23 gene as a cause of tumoral calcinosis.
Araya K; Fukumoto S; Backenroth R; Takeuchi Y; Nakayama K; Ito N; Yoshii N; Yamazaki Y; Yamashita T; Silver J; Igarashi T; Fujita T
J Clin Endocrinol Metab; 2005 Oct; 90(10):5523-7. PubMed ID: 16030159
[TBL] [Abstract][Full Text] [Related]
15. Familial tumoral calcinosis caused by a novel FGF23 mutation: response to induction of tubular renal acidosis with acetazolamide and the non-calcium phosphate binder sevelamer.
Lammoglia JJ; Mericq V
Horm Res; 2009; 71(3):178-84. PubMed ID: 19188744
[TBL] [Abstract][Full Text] [Related]
16. A novel GALNT3 mutation in a pseudoautosomal dominant form of tumoral calcinosis: evidence that the disorder is autosomal recessive.
Ichikawa S; Lyles KW; Econs MJ
J Clin Endocrinol Metab; 2005 Apr; 90(4):2420-3. PubMed ID: 15687324
[TBL] [Abstract][Full Text] [Related]
17. Human sterile alpha motif domain 9, a novel gene identified as down-regulated in aggressive fibromatosis, is absent in the mouse.
Li CF; MacDonald JR; Wei RY; Ray J; Lau K; Kandel C; Koffman R; Bell S; Scherer SW; Alman BA
BMC Genomics; 2007 Apr; 8():92. PubMed ID: 17407603
[TBL] [Abstract][Full Text] [Related]
18. Tumoral calcinosis: new insights for the rheumatologist into a familial crystal deposition disease.
Sprecher E
Curr Rheumatol Rep; 2007 Jun; 9(3):237-42. PubMed ID: 17531178
[TBL] [Abstract][Full Text] [Related]
19. A homozygous missense mutation in human KLOTHO causes severe tumoral calcinosis.
Ichikawa S; Imel EA; Kreiter ML; Yu X; Mackenzie DS; Sorenson AH; Goetz R; Mohammadi M; White KE; Econs MJ
J Clin Invest; 2007 Sep; 117(9):2684-91. PubMed ID: 17710231
[TBL] [Abstract][Full Text] [Related]
20. FGF23-S129F mutant bypasses ER/Golgi to the circulation of hyperphosphatemic familial tumoral calcinosis patients.
Shawar SM; Ramadan AR; Ali BR; Alghamdi MA; John A; Hudaib FM
Bone; 2016 Dec; 93():187-195. PubMed ID: 26620085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
